News

Grip strength predicts cardiovascular mortality


 

References

Grip strength measurement is a quick and inexpensive way to stratify an individual’s risk of all-cause mortality, and can be a strong predictor of cardiovascular mortality and a moderately strong predictor of incident cardiovascular disease, according to new research in The Lancet.

In a large, longitudinal population study, nearly 140,000 participants identified from the Prospective Urban-Rural Epidemiology (PURE) study were examined during 2003-2009. Grip strength was measured via handgrip dynamometer.

After adjustment, grip strength was inversely associated with all-cause mortality (hazard ratio per 5-kg reduction in grip strength 1.16), cardiovascular mortality (1.17), noncardiovascular mortality (1.17), myocardial infarction (1.07), and stroke (1.09). The results were highly statistically significant and largely similar across various socioeconomic groups, although risk of cancer and grip strength were positively associated more often among patients in higher-income countries than in middle- and lower-income countries, reported Dr. Darryl P. Leong of McMaster University, Hamilton, Ont., and his colleagues.

The researchers also attempted to assess the prognostic value of grip strength on other medical conditions, but “found no significant association” between grip strength and incident diabetes and no association between grip strength and risk of hospital admission for pneumonia or COPD, injury from fall, or fracture.

“Our study suggests that measurement of grip strength is a simple, inexpensive risk-stratifying method to assess risk of death, particularly in individuals who develop a major illness, and that muscle strength is a risk marker for incident cardiovascular disease in a number of countries and populations,” the investigators wrote.

Read the entire article here.

mbock@frontlinemedcom.com

Recommended Reading

Threat of cardiac arrest related to sports minimal
MDedge Cardiology
Thrombectomy fails to improve PCI outcomes, ups stroke risk
MDedge Cardiology
Costs a wash between CTA and functional chest pain testing
MDedge Cardiology
FDA panel cautiously backs approval of short-acting IV antiplatelet drug
MDedge Cardiology
Screen for acute stress disorder in ACS patients
MDedge Cardiology
Unrecognized diabetes common in acute MI
MDedge Cardiology
Prehospital mechanical CPR doesn’t improve survival
MDedge Cardiology
Testosterone therapy has neutral cardiovascular effects
MDedge Cardiology
Applications expand for vorapaxar in cardiovascular prevention
MDedge Cardiology
Ultrasound accurately predicts trauma thoracotomy survival
MDedge Cardiology